Medpace Holdings, Inc.

MEDP Healthcare Diagnostics & Research

Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.

Revenue
+8.50%
EPS
+24.6%
Free cash flow
−16.6%

Quarter to September 2026, against a year earlier

634.63 22.14 −3.37%
Market cap
$17.8B
P/E
34.6×
Fwd P/E
35.8×
Dividend yield
—
F-score
8/9
Altman Z
8.04
Beneish M
−2.92
Dividend safety
n/a

Medpace Holdings, Inc. (MEDP) Book value per share

Alert me on Book value per share

Medpace Holdings, Inc.'s book value per share at the end of fiscal 2025 was 15.9×, down 40.3% from 26.7× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 20.9×. Over the past ten years it has ranged from 11.9× (fiscal 2022) to 26.7× (fiscal 2024); the current reading is higher than 36% of that period. Medpace Holdings, Inc. ranks 13th of 49 Diagnostics & Research companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 15.9× (40.32%)
FY2024 26.7× 46.57%
FY2023 18.2× 52.51%
FY2022 11.9× (55.10%)
FY2021 26.6× 17.51%
FY2020 22.6× 11.71%
FY2019 20.2× 22.01%
FY2018 16.6× 28.67%
FY2017 12.9× (24.66%)
FY2016 17.1× 29.72%

Quarterly newest first

Period Book value per share Change
Sep 2026 20.9× 35.95%
Jun 2026 15.4× (26.79%)
Mar 2026 21.0× 32.17%
Dec 2025 15.9× 52.49%
40 more quarters

Against its own ten years

Low 11.9× High 26.7×
Ten-year median 17.1×
Current reading's percentile 36

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on MEDP